EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management

Cody Olson, Marlene Maria Girón Bravo, Gisela Gonzalez, Mary Elizabeth Camp

Focus · 2026-04 · 24 (2) · 179-187

DOI: 10.1176/appi.focus.20250042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Focus, 2026-04. Verfasst von Cody Olson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Texas Southwestern, Dallas. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurocognitive disorders (NCDs) encompass various conditions that affect cognition and functioning in activities of daily living. Although many types of NCDs lack curative therapy, medications may be used to ameliorate cognitive as well as behavioral and psychological symptoms of dementia (BPSD). Medications classified as acetylcholinesterase inhibitors, N-methyl-D-aspartate receptor antagonists, and antiamyloid monoclonal antibodies target cognitive symptoms. For BPSD, antidepressants, antipsychotics, mood stabilizers, anxiolytics, and stimulants have been studied. Selection of pharmacotherapies requires careful risk-benefit analysis for individual patients. This review discusses available evidence to guide these discussions and clinical decisions.

Schlagwörter

Stichwörter der Autor:innen

Behavioral and Psychological Symptoms of DementiaCognitionDementiaNeurocognitive disorders

Autor:innen und Institutionen

  • Department of Psychiatry, University of Texas Southwestern, Dallas.

Zitieren

APA

Olson, C., Girón Bravo, M. M., Gonzalez, G., & Camp, M. E. (2026). Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management. Focus, 24(2), 179-187. https://doi.org/10.1176/appi.focus.20250042

Vancouver

Olson C, Girón Bravo MM, Gonzalez G, Camp ME. Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management. Focus. 2026;24(2):179-187. doi:10.1176/appi.focus.20250042

BibTeX
@article{Olson2026,
  author = {Olson, Cody and Girón Bravo, Marlene Maria and Gonzalez, Gisela and Camp, Mary Elizabeth},
  title = {Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management},
  journal = {Focus},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {179--187},
  doi = {10.1176/appi.focus.20250042}
}
Kostenlos starten →